Sale!

DRPLA Dentatorubral-Pallidoluysian Atrophy Gene Analysis Test Cost

Original price was: 1,430 د.إ.Current price is: 1,290 د.إ.

-10%

The DRPLA (Dentatorubral-Pallidoluysian Atrophy) Gene Analysis Test is a specialized diagnostic procedure available at DNA Labs UAE, aimed at detecting mutations in the ATN1 gene, which are responsible for the development of Dentatorubral-Pallidoluysian Atrophy (DRPLA). DRPLA is a rare, hereditary neurodegenerative disorder that affects the brain, leading to a wide range of symptoms including involuntary movements, mental and emotional problems, and a decline in motor skills.

This genetic test involves analyzing the patient’s DNA to identify the specific mutations in the ATN1 gene, offering crucial information for the diagnosis, management, and understanding of the patient’s condition. The process is designed to be both accurate and comprehensive, ensuring a reliable diagnosis for affected individuals or those at risk of developing the condition.

At DNA Labs UAE, the DRPLA Gene Analysis Test is priced at 1290 AED. The cost reflects the sophisticated technology and expertise required to perform this detailed genetic analysis. For patients and families dealing with DRPLA or with a history of the disorder, this test provides a valuable tool for making informed decisions about their health and managing the condition effectively.

Description

DRPLA Dentatorubral-Pallidoluysian Atrophy Gene Analysis Test

Test Cost: AED 1290.0

Symptoms, Diagnosis, and Test Details:

Test Name: DRPLA Dentatorubral-Pallidoluysian Atrophy Gene Analysis
Test Components: ATN1 CAG Repeat
Price: AED 1290.0
Sample Condition: 4 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE.
Duly Filled Genomics Clinical Information Requisition Form (Form 20): Mandatory
Report Delivery: Sample collected on Monday by 11am; Report delivered on Friday
Method: PCR Fragment Analysis
Test Type: Neurologic Disorder
Doctor: Neurologist
Test Department: Molecular Diagnostics
Pre Test Information: Duly Filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.

DRPLA (Dentatorubral-Pallidoluysian Atrophy) Gene Analysis:

DRPLA gene analysis is a diagnostic test used to identify mutations in the ATN1 gene, which is responsible for causing DRPLA. DRPLA is a rare genetic disorder characterized by progressive damage to certain areas of the brain, leading to symptoms such as involuntary muscle movements, seizures, cognitive decline, and psychiatric problems.

The DRPLA gene analysis test involves analyzing a person’s DNA sample, usually obtained through a blood sample or cheek swab, to identify any mutations or changes in the ATN1 gene. The test can detect various types of mutations, including expansions of the CAG trinucleotide repeat sequence in the gene. These expansions result in the production of an abnormal protein that causes the characteristic symptoms of DRPLA.

The test is typically ordered by a healthcare provider if there is a suspicion of DRPLA based on a person’s symptoms and family history. It can help confirm the diagnosis and provide important information for genetic counseling and family planning. The test may also be used for prenatal diagnosis in families with a known ATN1 gene mutation.

It is important to note that the DRPLA gene analysis test is a specialized test that may not be available in all healthcare facilities. It is typically performed in specialized genetic testing laboratories that have the expertise to accurately analyze and interpret the results. Genetic counseling is often recommended before and after the test to discuss the implications of the results and provide support and guidance to individuals and families affected by DRPLA.

Test Name	DRPLA DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY GENE ANALYSIS Test
Components	*ATN1 CAG Repeat
Price	1290.0 AED
Sample Condition	4 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Report Delivery	Sample Mon by 11am;ReportFri
Method	PCR Fragment Analysis
Test type	Neurologic Disorder
Doctor	Neurologist
Test Department:	MOLECULAR DIAGNOSTICS
Pre Test Information	Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Test Details	DRPLA (Dentatorubral-pallidoluysian atrophy) gene analysis is a diagnostic test used to identify mutations in the ATN1 gene, which is responsible for causing DRPLA. DRPLA is a rare genetic disorder characterized by progressive damage to certain areas of the brain, leading to symptoms such as involuntary muscle movements, seizures, cognitive decline, and psychiatric problems. The DRPLA gene analysis test involves analyzing a person’s DNA sample, usually obtained through a blood sample or cheek swab, to identify any mutations or changes in the ATN1 gene. The test can detect various types of mutations, including expansions of the CAG trinucleotide repeat sequence in the gene. These expansions result in the production of an abnormal protein that causes the characteristic symptoms of DRPLA. The test is typically ordered by a healthcare provider if there is a suspicion of DRPLA based on a person’s symptoms and family history. It can help confirm the diagnosis and provide important information for genetic counseling and family planning. The test may also be used for prenatal diagnosis in families with a known ATN1 gene mutation. It is important to note that the DRPLA gene analysis test is a specialized test that may not be available in all healthcare facilities. It is typically performed in specialized genetic testing laboratories that have the expertise to accurately analyze and interpret the results. Genetic counseling is often recommended before and after the test to discuss the implications of the results and provide support and guidance to individuals and families affected by DRPLA.